CRESCENT BIOPHARMA, INC. — Director's Dealing 2018

Jan 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLYCOMIMETICS INC (GLYC)
CIK: 0001253689
Period of Report: 2018-01-10

Reporting Person: Hahn Brian M. (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-10	Employee Stock Option (right to buy)	$20.03	A	65000	Acquired	2028-01-09	Common Stock (65000)	Direct

Footnotes

F1: One-fourth of the shares underlying this option vest on January 10, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.